撤回：细胞周期蛋白依赖性激酶20（CDC20）可能作为基于生物标志物的风险评分系统用于预测肝细胞癌患者的预后。
Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
作者信息
Longevity Oxidative Medicine And Cellular
出版信息
Oxid Med Cell Longev. 2023 Aug 2;2023:9806284. doi: 10.1155/2023/9806284. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/8421813.].
摘要
[本文撤回文章DOI: 10.1155/2022/8421813。]
相似文献
1
Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.撤回：细胞周期蛋白依赖性激酶20（CDC20）可能作为基于生物标志物的风险评分系统用于预测肝细胞癌患者的预后。
Oxid Med Cell Longev. 2023 Aug 2;2023:9806284. doi: 10.1155/2023/9806284. eCollection 2023.
2
CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.CDK20 可作为预测肝细胞癌患者预后的潜在基于生物标志物的风险评分系统。
Oxid Med Cell Longev. 2022 Sep 19;2022:8421813. doi: 10.1155/2022/8421813. eCollection 2022.
3
Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.撤回：基于综合生物信息学分析鉴定HMMR基因作为肝细胞癌的诊断和预后生物标志物。
Evid Based Complement Alternat Med. 2023 Sep 27;2023:9819147. doi: 10.1155/2023/9819147. eCollection 2023.
4
A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma.基于 CDC20 和 FCN3 的新型基因标志物预测肝细胞癌患者的预后和免疫特征。
J Immunol Res. 2022 Mar 30;2022:9117205. doi: 10.1155/2022/9117205. eCollection 2022.
5
Retracted: Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.撤回：基于生物信息学方法的肝细胞癌铁死亡预后预测及分子机制
Comput Math Methods Med. 2023 Jul 19;2023:9782763. doi: 10.1155/2023/9782763. eCollection 2023.
6
Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.撤回：G蛋白亚基γ5是一种预后生物标志物，与肝细胞癌中的免疫浸润相关。
Dis Markers. 2023 Jul 19;2023:9806936. doi: 10.1155/2023/9806936. eCollection 2023.
7
Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.撤回：用于预测肝细胞癌患者生存的胆汁酸相关基因特征的开发。
Comput Math Methods Med. 2023 Dec 6;2023:9865740. doi: 10.1155/2023/9865740. eCollection 2023.
8
The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma.病毒感染相关基因CDC20在肝细胞癌预后及免疫浸润中的新作用的生物信息学与实验分析
Aging (Albany NY). 2022 May 27;14(10):4513-4529. doi: 10.18632/aging.204093.
9
Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.鉴定 CDC20 作为肝癌免疫浸润相关的预后生物标志物。
Invest New Drugs. 2021 Oct;39(5):1439-1453. doi: 10.1007/s10637-021-01126-1. Epub 2021 May 3.
10
Retracted: Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma.撤稿：钆塞酸二钠磁共振成像在预测肝细胞癌微血管侵犯中的性能分析。
Contrast Media Mol Imaging. 2023 Dec 13;2023:9761084. doi: 10.1155/2023/9761084. eCollection 2023.
本文引用的文献
1
CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.CDK20 可作为预测肝细胞癌患者预后的潜在基于生物标志物的风险评分系统。
Oxid Med Cell Longev. 2022 Sep 19;2022:8421813. doi: 10.1155/2022/8421813. eCollection 2022.
Zotero 插件